Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
12/2003
12/18/2003US20030232840 Oxazolidinone photoaffinity probes
12/18/2003US20030232810 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003US20030232008 Oxazolidinone photoaffinity probes
12/18/2003CA2488493A1 Amidine derivatives for treating amyloidosis
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/17/2003EP1371650A1 Activator for peroxisome proliferator-activated receptor
12/17/2003EP1371649A1 Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
12/17/2003EP1370541A1 Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664281 Oxazol-4-yl-alkoxy- or alkthioxy- functionality; peroxisome proliferator activated receptor regulators
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003US20030229135 Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxycarbonyl]-5-oxazolidine carboxylic acids
12/11/2003US20030229132 Small molecule modulators of apoptosis
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229086 Central nervous system disorders; side effect reduction
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003CA2487475A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
12/10/2003EP1369861A2 Optical recording media
12/10/2003EP1368334A2 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
12/10/2003EP1368326A2 Oxazolidinone photoaffinity probes
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0893995B1 Anticachectic composition
12/10/2003CN1461325A Method for applying polymeric lens coating
12/10/2003CN1130386C Secondary cross-linking of hydrogels with 2-oxazolidinones
12/10/2003CN1130361C Process for producing isooxazolidinedione compound
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/09/2003US6660869 Preparation of an aromatic bisoxazoline
12/09/2003US6660858 2-aminobenzoxazole derivatives and combinatorial libraries thereof
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/09/2003CA2123697C Novel substituted salicylic acids
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099767A1 Amide derivatives as inhibitors of the enzymatic activity of renin
12/04/2003WO2003099766A1 (2s)-2-ethylphenylpropionic acid derivative
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003US20030225292 Clean, high-yield preparation of S,S and R,S amino acid isosteres
12/04/2003US20030225161 GABA and L-glutamic acid analogs for antiseizure treatment
12/04/2003US20030225131 Thrombin inhibitors
12/04/2003US20030225127 Heterocyclic sulfonamide derivatives
12/04/2003US20030225107 Cyclopropyl containing oxazolidinone antibiotics and derivatives thereof
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225083 Oxazole derivatives, such as 3-(4-(2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy)-2-(pyridin-2-ylmethoxy) -phenyl)-propionic acid
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003EP1367052A2 Intermediate for the preparation of carvedilol
12/03/2003EP1366766A1 Inhibitors of IMPDH enzyme
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP1283838B1 Piperazine and piperidine compounds
12/03/2003CN1129592C Method for preparation of citalopram
12/03/2003CN1129583C Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
12/03/2003CN1129429C Potassium sodium and tris oxaprozin salt pharmaceutical formulations
12/02/2003US6657086 For reducing weight in mammals; preventing and treating obesity
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
11/2003
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097617A1 Cysteine protease inhibitors
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030219662 Electrophotographic organophotoreceptors with novel charge transport compounds
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2484011A1 Cysteine protease inhibitors
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003CN1458925A Lipo-or amphlic scintillators and their use in assays
11/25/2003US6653334 Benzoxazole compound and pharmaceutical composition containing the same
11/25/2003US6653314 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
11/25/2003US6653309 Binding ligands
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/24/2003CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2002064558A3 Oxazole derivatives, their preparation and their use as cytokine inhibitors
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003US20030216572 Process to produce oxazolidinones
11/20/2003US20030216456 Benzoxazole derivatives as novel melatonergic agents
11/20/2003US20030216443 Antidiabetic agents; using mixture of enzyme inhibitors
11/20/2003US20030216442 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 210